CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Free Report)’s stock is scheduled to reverse split before the market opens on Wednesday, June 5th. The 1-50 reverse split was announced on Wednesday, June 5th. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, June 5th. CNS Pharmaceuticals Price Performance NASDAQ:CNSP traded […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 204,400 shares, a decrease of 11.1% from the April 30th total of 229,900 shares. Based on an average daily volume of 159,600 shares, […]
Shares of CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Free Report) are set to reverse split on the morning of Wednesday, June 5th. The 1-50 reverse split was announced on Wednesday, June 5th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, June 5th. CNS Pharmaceuticals Stock Performance NASDAQ CNSP […]
Rafferty Asset Management LLC boosted its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 27.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 427,930 shares of the biopharmaceutical company’s stock after purchasing an additional 91,317 shares during the period. Rafferty […]
Rafferty Asset Management LLC boosted its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 27.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 427,930 shares of the biopharmaceutical company’s stock after purchasing an additional 91,317 shares during the period. Rafferty […]